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Abstract
Background: Insulin resistance is the primary metabolic disorder associated with obesity; yet little is known about its 
role as a determinant of the metabolic syndrome in obese children. The aim of this study is to assess the association 
between the degree of insulin resistance and the different components of the metabolic syndrome among obese 
children and adolescents.
Methods: An analytical, cross-sectional and population-based study was performed in forty-four public primary 
schools in Campeche City, Mexico. A total of 466 obese children and adolescents between 11-13 years of age were 
recruited. Fasting glucose and insulin concentrations, high density lipoprotein cholesterol, triglycerides, waist 
circumference, systolic and diastolic blood pressures were measured; insulin resistance and metabolic syndrome were 
also evaluated.
Results: Out of the total population studied, 69% presented low values of high density lipoprotein cholesterol, 49% 
suffered from abdominal obesity, 29% had hypertriglyceridemia, 8% presented high systolic and 13% high diastolic 
blood pressure, 4% showed impaired fasting glucose, 51% presented insulin resistance and 20% metabolic syndrome. 
In spite of being obese, 13% of the investigated population did not present any metabolic disorder. For each one of the 
components of the metabolic syndrome, when insulin resistance increased so did odds ratios as cardiometabolic risk 
factors.
Conclusions: Regardless of age and gender an increased degree of insulin resistance is associated with a higher 
prevalence of disorders in each of the components of the metabolic syndrome and with a heightened risk of suffering 
metabolic syndrome among obese children and adolescents.
Background
The World Health Organization recognizes overweight
and obesity in children and adolescents as worldwide
public health problems. Mexico is one of the countries
which suffer most from these.
Indeed, according to Mexican National Health and
Nutrition Surveys, in 1999 [1] the combined prevalence
of overweight and obesity in school-age children was
18.6%; by 2006, such prevalence had increased to 26%,
which represents an average increase of 1.1 percentage
points per year [2].
Insulin resistance (IR) is the primary metabolic disor-
der associated with obesity and is defined as a diminished
ability of insulin to stimulate glucose uptake by skeletal
muscle and adipose tissue, in addition to reducing insu-
lin's ability to suppress hepatic glucose production and
output [3]. Some of the several disorders associated with
IR that have been described include systemic inflamma-
tion, increases in fibrinolysis, endothelial dysfunction,
and atherosclerosis [4], all of which can first appear dur-
ing childhood in obese individuals [5]. Although the
hyperinsulinemic-euglycemic clamp is considered the
gold standard for evaluating and measuring IR, the tech-
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nical difficulties associated with this method have led to
the development of less invasive methods. Among these,
the homeostasis model assessment of insulin resistance
index (HOMA-IR) is one of the most commonly used [6].
It is worth noting that no consensus exists concerning the
HOMA-IR cut-off points that define IR among the pedi-
atric population, although there is general agreement that
IR is a common pathway for the development of glucose
metabolism disorders, dyslipidemias, and high blood
pressure, all of which are components of the metabolic
syndrome (MS) [7-9]. In turn, MS is a risk factor for the
subsequent development of type-2 diabetes mellitus
(T2DM) and cardiovascular disease (CVD) [10].
Among children, MS is not well characterized, and
there is a lack of agreement as to its components and cut-
off points, though most authors include among the for-
mer abdominal obesity, high blood pressure, glucose
abnormalities, and dyslipidemias [11,12]. Due to this lack
of consensus, the reported prevalence of MS among chil-
dren and adolescents shows a great deal of variability
[13,14]. For instance, in studies including children and
adolescents with varying nutritional conditions, the prev-
alence lies between 2.5% and 12.9% [13]. However, when
only overweight and obese children and adolescents are
included, the prevalence increases and falls within the
range 26% -31.2% [13-15].
In children and adolescents, a direct relationship
between the degree of obesity and the prevalence of MS
has been reported [16,17]; however, it is not exactly
known how and to what extent IR is associated with each
of the components of MS. In this context, this study aims
to elucidate the prevalence of IR and to evaluate the asso-
ciation of IR with each of the components of MS among
obese children and adolescents.
Methods
The study was conducted in all of the forty-four schools
that compose the public school system in Campeche City,
Mexico.
Prior to the study, ethical clearance was obtained from
Campeche State research ethics committees and school
authorities. The study consisted of two stages, the first of
which aimed to identify children suffering from obesity.
For this purpose, weight and height were measured by
four nurses previously trained to follow international
anthropometric guidelines. The study included 4,937
children between 11 and 13 years of age attending the 5th
and 6th grades. Obesity was defined as a body mass index
(BMI) percentile ≥95th  for the child's age and gender
according to the Centers for Disease Control (CDC) 2000
references [18]. Following this criterion, 1,475 children
were classified as obese. Out of this total, written parental
and child informed consent was obtained from 600 ran-
domly selected children. From this group, complete
blood samples were collected from 466 children.
During the second stage, blood pressure (BP) was
obtained using the auscultatory method, and waist cir-
cumference (WC) was measured with children in the
standing position, placing the metric strip at the mid-
point between the lower rib and the iliac crest after a nor-
mal exhalation. In addition, a sample of venous blood was
obtained after a 12-hour fast in order to determine con-
centrations of insulin by chemiluminescence immunoas-
say (Access Beckman Coulter Instruments, Brea
California), glucose, and plasma lipids by an enzymatic
method, and high density lipoprotein cholesterol (HDL-
C) assayed by the addition of magnesium ions (Synchron
CX® Beckman Instruments, Brea California). In all cases,
commercial enzymatic kits were employed. Low density
lipoprotein cholesterol (LDL-C) levels were estimated
using the Friedewald formula, as modified by De Long
[19].
Definition of MS and its components
MS was defined according to guidelines by the Interna-
tional Diabetes Federation (IDF) [12], the only exception
b e i n g  t h a t  t h e  B P  c r i t e r i a  w e r e  u s e d  a c c o r d i n g  t o  t h e
North American Task Force guidelines [20]. For each of
the components of MS, the following cut-off points were
used: Hypertriglyceridemia (triglycerides ≥ 150 mg/dL),
low HDL-C (HDL-C ≤ 40 mg/dL), high blood pressure
(systolic and/or diastolic BP ≥ 90th percentile for chil-
dren's age, gender, and height), impaired fasting glucose
(fasting glucose ≥ 100 mg/dL), and abdominal obesity
(WC ≥ percentile 90th for children's age, gender, and eth-
nic origin) [21]. MS was diagnosed when three or more of
the previously described components were present.
Hypercholesterolemia (total cholesterol ≥ 200 mg/dL)
and high values of LDL-C (LDL-C ≥ 130 mg/dL) were
defined according by the American Academy of Pediat-
rics [22].
Definition of IR
IR was determined through HOMA-IR, which was calcu-
lated using the following equation: [(fasting glucose (mg/
dL))(fasting insulin (μU/mL))/405)] [23]. A HOMA-IR
value of 3.4 was chosen as the cut-off point to define IR as
it has been suggested that beyond this value, which corre-
sponds to the 90th percentile of a population of healthy
children, IR becomes a cardiovascular risk factor [24].
Statistical analysis
Means and standard deviations and prevalence of anthro-
pometric and metabolic variables were obtained. These
measures were compared by gender using Student's t test
or X2 test. Four categories were derived for HOMA-IR
percentiles: <25th, 25-49.9th, 50-74.9th, and ≥75th. In order
to assess the risk of presenting disorders in each of theJuárez-López et al. BMC Public Health 2010, 10:318
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MS components, measures of these were compared
according to the aforementioned HOMA-IR percentile
categories through logistic regression analysis. Statisti-
cally significant differences were assumed if the P-value
was < 0.05.
Data were processed with ST A T A, SE v .9.0, and EPI-
INFO 3.3.2 according to the CDC 2000 reference [18].
Results
Table 1 depicts the anthropometric features, BP and met-
abolic profile of the obese children and adolescents who
participated in the study. For both sexes, the mean age
was 11.3, SD 0.8 years; the mean BMI, 27.3 kg/m², SD 3.0,
which corresponds to the 97.5th percentile for age and
gender; and the mean WC, 85.0 cm, SD 7.8.
No difference was observed between sexes in the values
of systolic and diastolic BP. However, in both sexes sys-
tolic BP fell into the 49.5th percentile, whereas diastolic
BP fell into the 60.9th percentile, according to the refer-
ence values for gender, age, and height [20] (these data are
not shown in the tables).
The same table summarizes the values of glucose, insu-
lin, and lipids in the investigated children and adolescent
population. Girls exhibited a higher concentration of fast-
ing insulin and higher HOMA-IR values compared to
boys, but smaller concentrations of fasting glucose, total
cholesterol, and LDL-C.
Table 2 depicts the prevalence of cardiometabolic risk
factors and the components of MS among the study par-
ticipants. The prevalence of the components of MS in this
population was as follows: abdominal obesity, 49%; high
systolic BP, 8%; high diastolic BP, 13%; impaired fasting
glucose, 4%; hypertriglyceridemia, 29%; and low HDL-C,
69%. Although 56% of the population suffered from
hyperinsulinemia, this condition was observed in 71% of
girls but only in 45% of boys (P < 0.001); likewise, IR was
more common among girls than boys, 63% versus 43%,
respectively (P  < 0.001). The prevalence of heightened
total cholesterol levels was higher among boys (14%) than
girls (7%) (P = 0.013), a similar pattern also found in rela-
tion to increased LDL-C values, where the prevalence
was 15% and 6% (P = 0.004) among boys and girls, respec-
tively. Although 13% of these children and adolescents
did not have any components associated with MS, 20%
had three or more of such components.
Using the group with HOMA-IR values below the 25th
percentile as a reference, table 3 shows how, for each one
of the components of MS, when IR increases so does the
"odds ratio (OR)" as a cardiometabolic risk factor. WC
begins to be significant from the 25th percentile of IR (P =
Table 1: Anthropometric measures, blood pressure and metabolic profile of obese children and adolescents
Features Total n = 466 Boys n = 272 (58.4%) Girls n = 194(41.6%) P*
Age (years) 11.3 (0.8) 11.3 (0.8) 11.3 (0.8) 0.629
Anthropometric Measures
Weight (Kg) 59.7 (10.0) 59.0 (10.2) 60.7 (9.6) 0.075
Height (m) 1.5 (0.7) 1.5 (0.7) 1.5 (0.6) 0.119
Body mass index (kg/m2) 27.3 (3.0) 27.1 (3.0) 27.5 (2.9) 0.164
Body Mass Index Percentile 97.5 (1.2) 97.6 (1.2) 97.3 (1.3) 0.010
Waist circumference (cm) 85.0 (7.8) 86.2 (8.1) 83.4 (7.1) <0.001
Blood Pressure (mmHg)
Systolic 105.7 (10.1) 106.2 (10.0) 105.0 (10.2) 0.189
Diastolic 66.2 (8.6) 66.3 (8.9) 66.1 (8.3) 0.822
Metabolic profile
Glucose (mg/dL) 88.7 (6.6) 89.2 (6.7) 87.9 (6.5) 0.033
Insulin (μU/mL) 18.8 (12.1) 16.9 (11.3) 21.5 (12.7) <0.001
HOMA-IR& 4.2 (2.9) 3.8 (2.8) 4.7 (2.9) <0.001
Total cholesterol (mg/dL) 166.1 (30.2) 169.2 (32.5) 161.9 (26.1) 0.010
Triglycerides (mg/dL) 135.0 (75.3) 132.9 (77.1) 137.8 (72.8) 0.489
LDL-C (mg/dL) 101.2 (25.5) 104.3 (27.7) 96.9 (21.3) 0.002
HDL-C (mg/dL) 38.0 (8.2) 38.3 (8.4) 37.5 (7.9) 0.267
All values are means (standard deviations).
* P value according to Student's t test comparing boys and girls.
&HOMA-IR: [(fasting glucose (mg/dL))(fasting insulin (μU/mL))/405)]Juárez-López et al. BMC Public Health 2010, 10:318
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0.014). From the 50th percentile onwards, in addition to
WC, also diastolic BP, glucose and triglycerides become
significant (P < 0.05). Above the 75th percentile, all of the
OR are significant (P < 0.05), except systolic and diastolic
BP.
Likewise, Table 4 shows the ORs of suffering MS
according to IR categories. From this table, it is apparent
that the Odds of developing MS (adjusted for gender and
age) increases as a function of IR. Such OR is 5.5 (95% CI
2.6-11.6) times greater when IR is above the 75th percen-
tile.
Discussion
Our results show that higher levels of IR are associated
with a greater degree of alterations in the components of
the MS in the population studied, half of which presented
IR.
The apparently normal fasting glucose levels in this
population are maintained by a compensatory mecha-
nism based on hyperinsulinism, which is reflected in
HOMA-IR values [25]. However, when impaired fasting
glucose prevalence is analyzed through ORs, it is possible
to observe that increased levels of IR are associated with
rising OR.
Girls presented the highest insulin levels and HOMA-
IR values, along with lower glucose concentrations. This
pattern could be a consequence of the fact that, at equal
ages, girls can enter puberty up to two years earlier than
boys [26,27] - therefore, more girls would have reached
higher pubertal stages. However - and this is a limitation
of this study - no information was collected about either
pubertal stage or growth and sexual hormones, factors
which could influence the prevalence of the rise in IR
[28].
In accordance with previous studies on adolescents and
adults, the IR reported in this study is associated with the
primary alterations in the lipid profile; hyperinsulinism
increases the free fatty acid release and the triglyceride
synthesis, which results in hypertriglyceridemia [29,30].
Likewise increased hepatic lipase activity can account for
the rise in high-density lipoprotein depuration, produc-
ing hypoalphalipoproteinemia [31]. However, the high
prevalence of low C-HDL levels observed in this study is
one of the highest reported in the literature [13,30,32].
Regardless of its cause, it is a risk factor for the develop-
Table 2: Prevalence of cardiometabolic risk factors in obese children and adolescents
Total (n = 466) Boys (n = 272) Girls (n = 194) P*
Waist circumference ≥ 90 pc a 49 48 51 0.491
Systolic BP ≥ 90 pc b 8 10 7 0.272
Diastolic BP ≥ 90 pc b 13 14 11 0.579
Glucose ≥ 100 mg/dL c 462 0 . 0 6 3
Insulin ≥ 15 μU/mL d 56 45 71 <0.001
HOMA-IR (≥ 3.4) d 51 43 63 <0.001
Total cholesterol ≥ 200 mg/dL e 11 14 7 0.013
Triglycerides ≥ 150 mg/dL c 29 28 31 0.431
LDL-C ≥ 130 mg/dL e 11 15 6 0.004
HDL-C < 40 mg/dL c 69 68 71 0.495
Metabolic syndrome components c
01 3 1 5 1 0 0 . 1 6 2
13 0 2 8 3 1 0 . 4 6 5
23 7 3 6 3 8 0 . 7 0 0
≥3 components c 20 21 20 0.898
All values are percentages.
a According to Waist Circumference percentiles of Mexican-American children [21].
b According to National High Blood Pressure Education Program [20].
c According to International Diabetes Federation (IDF) criteria [12].
d Insulin and HOMA-IR According to the cardiovascular risk cut-off points [24].
e According to Committee on Nutrition of the American Academy of Pediatrics [22].
*P value according to X2 test comparing boys and girls.Juárez-López et al. BMC Public Health 2010, 10:318
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m e n t  o f  c a r d i o v a s c u l a r  e v e n t s  d u r i n g  a d u l t h o o d .  S u c h
events stem from both genetic and environmental fac-
tors. Indeed, it has been reported that individuals of
Turkish descent display greater hepatic lipase activity,
which augments the depuration of this lipoprotein and is
associated with lower levels of HDL-C [33]. However, it is
not known whether population of Mexican descent could
have a polymorphism such as that identified among their
Turkish counterparts that may explain the higher preva-
l e n c e  o f  l o w  H D L - C  o b s e r v e d  i n  t h i s  s t u d y .  W h a t  i s
known is that, among individuals of Mexican descent, an
association has been described between a variant of gene
ABCA1 and lower HDL-C levels, along with a greater risk
of developing obesity, MS, and early onset T2DM [34]. As
far as environmental factors are concerned, lower levels
of this lipoprotein can be explained in terms of changing
eating habits [35]. The diet of Mexican children resem-
bles ever more that of their North American counterparts
[36], a diet rich in simple sugars and animal fats, but with
limited amounts of fiber [37].
Although the association between IR and OR of suffer-
ing high blood pressure was not statistically significant,
the observed trend in this population can be associated
with the different disorders stemming from obesity [7]
among which IR stands out [38]. Hyperinsulinism
increases renal sodium absorption and sympathetic tone
[39], which combines with altered vasodilatation, which
in turn is a secondary effect of nitric oxide deficient
secretion by the vascular endothelium [40]. Therefore, it
is to be expected that if such IR-induced hyperinsulinism
Table 3: Odds ratios of suffering cardiometabolic risk factors according to HOMA-IR percentiles in obese children and adolescents
Cardiometabolic risk factors HOMA-IR Percentile (values)
<25 (<2.4) 25-49.9 (2.4-3.3) 50-74.9 (3.4-4.9) ≥75 (≥5.0)
WCa ≥90 pc
OR Referent 2.0 3.3 5.2
95% CI - 1.2; 3.5 1.9; 5.8 2.9; 9.3
P - 0.014 <0.001 <0.001
Systolic BPb ≥ 90 pc
OR Referent 0.5 2.0 2.2
95% CI - 0.2; 1.9 0.8; 5.0 0.9; 5.6
P - 0.326 0.159 0.098
Diastolic BPb ≥ 90 pc
OR Referent 1.5 2.5 1.8
95% CI - 0.6; 3.5 1.1; 5.8 0.8; 4.3
P - 0.395 0.025 0.161
Glucose ≥ 100 mg/dL
OR Referent 1.9 4.9 5.0
95% CI - 0.3; 12.0 1.0; 24.7 1.0; 25.3
P - 0.475 0.052 0.050
Triglycerides ≥ 150 mg/dL
OR Referent 1.8 2.8 4.3
95% CI - 0.9; 3.5 1.5; 5.4 2.3; 8.2
P - 0.083 0.002 <0.001
HDL-C < 40 mg/dL
OR Referent 1.1 1.4 1.8
95% CI - 0.6; 1.9 0.8; 2.5 1.0; 3.2
P - 0.714 0.237 0.050
Values obtained through logistic regression, adjusted for gender and age
a WC: Waist circumference b BP: Blood pressureJuárez-López et al. BMC Public Health 2010, 10:318
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continues, permanent alterations such as atherosclerosis
and hypertension will eventually develop.
Furthermore, the prevalence of MS reported in this
study - around 20% - might stem from the employed defi-
nition, which relied on stricter cut-off points than those
used in other studies [11]. In studies where Cook's crite-
ria was applied, the prevalence of MS among North
American obese adolescents was 27% [16], in others fol-
lowing the III Adult Treatment Panel criteria, the preva-
lence was 26.1% [15].
In order to ascertain the real prevalence of this syn-
drome among children, agreement is needed concerning
the cut-off points for each of the syndrome's components;
likewise, categories for pubertal stage and gender need to
be established [41]. Notwithstanding the heterogeneity of
current definitions, the notion of MS has been useful for
identifying individual children at risk of developing CVD
and T2DM [42].
As mentioned above, 87% of the study participants pre-
sented at least some kind of functional or metabolic dis-
order. Nevertheless, in spite of being obese, almost 13% of
the study population did not present any kind of disorder,
a phenotype known as "metabolically healthy but obese
individuals" [43]. Among adults, a 9.7% prevalence of this
phenotype has been reported in the literature; interest-
ingly, within this group no family history of T2DM has
been found [44]. This suggests that protection against
cardiometabolic disorders, even in the presence of obe-
sity, can have genetic features [45].
A further limitation of this study derives from the fact
that cross-sectional studies are not able to establish cau-
sality, only associations between different variables.
However, given the close relationship between obesity,
IR, and MS - with its attendant risk of developing co-
morbidities, such as T2DM and CVD - it is imperative to
implement prevention, diagnosis, and early treatment
measures for obesity involving all sectors of society.
Conclusions
This study has confirmed that among obese children and
adolescents, regardless of age and gender, an increased
degree of insulin resistance is associated with a higher
prevalence of disorders in each of the components of the
metabolic syndrome and with a heightened risk of suffer-
ing MS.
HOMA-IR values above 3.4, which correspond to the
50th percentile of this population, were associated with an
increased risk of having MS, compared to the lowest per-
centile of HOMA-IR values.
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